Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Outset Medical Inc Investors Encouraged To Participate In Securities Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ: OM ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Investors Have Opportunity To Participate In Outset Medical Inc Securities Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 12, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Lost Money on Outset Medical, Inc. (OM)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Lost Money on Outset Medical, Inc.(OM)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Shareholder Rights Advocates at Levi & Korsinsky Investigate Outset Medical, Inc. (OM) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Outset Medical, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - OM
NEW YORK, NY / ACCESSWIRE / August 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Lost Money on Outset Medical, Inc. (OM)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
OM Investors Can Join Outset Medical, Inc. Securities Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ: OM ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
